Summary:
A Long term open label study of safety and tolerability of cariprazine as adunctive therapy in Major Depressive disorder.
Qualified Participants Must:
Be between 18 to 65 years of age
Currently be taking medication for Depression
Qualified Participants May Receive:
Free medical evaluation, free study medication and compensation for time and travel.